Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Current Taxes (2020 - 2025)

Marimed has reported Current Taxes over the past 6 years, most recently at $27.0 million for Q4 2025.

  • Quarterly Current Taxes rose 23.08% to $27.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $27.0 million through Dec 2025, up 23.08% year-over-year, with the annual reading at $27.0 million for FY2025, 23.08% up from the prior year.
  • Current Taxes was $27.0 million for Q4 2025 at Marimed, down from $28.1 million in the prior quarter.
  • Over five years, Current Taxes peaked at $28.1 million in Q3 2025 and troughed at $1.3 million in Q1 2021.
  • The 5-year median for Current Taxes is $14.2 million (2023), against an average of $14.0 million.
  • Year-over-year, Current Taxes skyrocketed 1462.79% in 2021 and then plummeted 30.23% in 2022.
  • A 5-year view of Current Taxes shows it stood at $16.5 million in 2021, then plummeted by 30.23% to $11.5 million in 2022, then rose by 25.63% to $14.4 million in 2023, then surged by 51.88% to $21.9 million in 2024, then grew by 23.08% to $27.0 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Current Taxes are $27.0 million (Q4 2025), $28.1 million (Q3 2025), and $25.4 million (Q2 2025).